Tarsus Pharmaceuticals, Inc. (TARS) vs Xenon Pharmaceuticals Inc. (XENE)
Tarsus Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc. are both Biotechnology companies. Tarsus Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc. are of similar size ($3.7B and $3.6B). Tarsus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 105.2% against −8.15%. Xenon Pharmaceuticals Inc. has the higher net margin (0.00% vs −7.67%) and the lower return on invested capital (−88.5% vs 0.00%). Across the 17 metrics below, Tarsus Pharmaceuticals, Inc. leads on 11 and Xenon Pharmaceuticals Inc. on 6.
Valuation
Profitability
| Metric | TARS | XENE | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.28% | 28.40% | 65.16% |
| Operating margin | (8.00%) | 0.00% | 0.00% |
| Net margin | (7.67%) | 0.00% | 0.00% |
| Free cash flow margin | 9.24% | 0.00% | 0.00% |
| Return on equity | (13.68%) | (43.62%) | (57.72%) |
| Return on assets | (8.40%) | (41.54%) | (49.22%) |
| Return on invested capital | 0.00% | (88.54%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack